Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2021-12-08 2021-05-20
Drug Identification Number 02489147 02489147
Brand name ERFA-AMIKACIN ERFA-AMIKACIN
Common or Proper name ERFA-AMIKACIN ERFA-AMIKACIN
Company Name SEARCHLIGHT PHARMA INC SEARCHLIGHT PHARMA INC
Ingredients AMIKACIN AMIKACIN
Strength(s) 250MG 250MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML 2ML
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-06-01 2021-06-01
Actual start date 2021-05-19 2021-05-19
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments SHORT-DATED STOCK AVAILABLE
Health Canada comments